Page 42 - ILAE_Lectures_2015

124. Bien CG, Bauer J. Autoimmune epilepsies. Neurotherapeutics 2014;11(2):311-318.
125. Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. The pathology of Rasmussen syndrome: stages

of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004;45:516-526.
126. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in

Rasmussen's encephalitis. Ann Neurol 2002;51:311-318.
127. Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European

consensus statement. Brain 2005;128:454-471.
128. Tobias SM, Robitaille Y, Hickey WF, Rhodes CH, Nordgren R, Andermann F. Bilateral Rasmussen encephalitis:

postmortem documentation in a five-year-old. Epilepsia 2003;44:127-130.
129. Giblin KA, Blumenfeld H. Is epilepsy a preventable disorder? New evidence from animal models. Neuroscientist

2010;16:253-275.
130. Pitkanen A. Therapeutic approaches to epileptogenesis--hope on the horizon. Epilepsia 2010;51 Suppl 3:2-17.
131. Loscher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and

translational research. Pharmacol Rev 2010;62:668-700.
132. Pitkanen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011;10:173-

186.